Lupin Limited, a pharmaceutical company headquartered in Mumbai, India has announced its plans to enter into a strategic business transfer agreement with its wholly-owned subsidiary, Lupin Manufacturing Solutions Limited (LMSL). This decision was approved by the company’s Board of Directors during their meeting held on September 11, 2023. After the news today shares of company …